✦ LIBER ✦

Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia

✍ Scribed by Apostolia Tsimberidou; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Srdan Verstovsek; Stephan Faderl; Maher Albitar; Hagop Kantarjian; Elihu Estey; Francis J. Giles

Book ID: 108403283
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 58 KB
Volume: 27
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(03)00022-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of gemtuzumab ozogamicin in com

The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia

✍ Hien K. Duong; Matt Kalaycio 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 178 KB

Pilot study of Mylotarg, idarubicin and

Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia

✍ Yesid Alvarado; Apostolia Tsimberidou; Hagop Kantarjian; Jorge Cortes; Guillermo 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 168 KB

Gemtuzumab ozogamicin plus cytarabine in

Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia

✍ Jérôme Doyen; Antoine Italiano; Frédéric Peyrade; Claude Bouyer; Antoine Thyss 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Decitabine combined with fractionated ge

Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia

✍ Saeeda Chowdhury; Stuart Seropian; Peter W. Marks 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Gemtuzumab, fludarabine, cytarabine, and

Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes

✍ Apostolia Tsimberidou; Elihu Estey; Jorge Cortes; Deborah Thomas; Stefan Faderl; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Background: Gemtuzumab is used to treat patients with previously untreated or recurrent acute myelogenous leukemia (aml). the fludarabine and cytarabine (ara-c) regimen is active in these patients. resistance to gemtuzumab is associated with blast multidrug resistance (mdr). the objectives of th

Sequential continuous infusion of fludar

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

✍ Andrea Camera; Ciro R. Rinaldi; Salvatore Palmieri; Nicola Cantore; Giuseppina M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 159 KB